His scientific interests lie mostly in Prostate cancer, Prostate, Radiology, Biopsy and Surgery. His biological study spans a wide range of topics, including Stage and Disease. His Prostate research is multidisciplinary, relying on both Predictive value of tests, Nuclear medicine and Phases of clinical research.
His biological study focuses on Magnetic resonance imaging. His Biopsy research incorporates themes from Prostate biopsy, Cancer and Image-Guided Biopsy. His work carried out in the field of Surgery brings together such families of science as Internal medicine, Renal cell carcinoma and Nephrectomy.
His primary areas of investigation include Prostate cancer, Internal medicine, Oncology, Radiology and Prostate. His work deals with themes such as Biopsy and Urology, which intersect with Prostate cancer. In the field of Internal medicine, his study on Prostate-specific antigen, Renal cell carcinoma and Androgen deprivation therapy overlaps with subjects such as In patient.
His Oncology study combines topics from a wide range of disciplines, such as Randomized controlled trial, PCA3, Castration resistant, Disease and Radiation therapy. His study in Radiology is interdisciplinary in nature, drawing from both Multiparametric Magnetic Resonance Imaging and Targeted biopsy. His Magnetic resonance imaging research integrates issues from Pathology and Image-Guided Biopsy.
His primary areas of study are Prostate cancer, Internal medicine, Oncology, Radiology and Prostate. His Prostate cancer study integrates concerns from other disciplines, such as Biopsy and MEDLINE. His work in the fields of Internal medicine, such as Randomized controlled trial and Nephrology, overlaps with other areas such as In patient and Text mining.
Samir S. Taneja has included themes like Androgen deprivation therapy and Radiation therapy in his Oncology study. He has researched Radiology in several fields, including PI-RADS, Prostate biopsy, Targeted biopsy and Multiparametric Magnetic Resonance Imaging. His Prostate research is multidisciplinary, incorporating perspectives in Effective diffusion coefficient, Medical physics, Disease and Retrospective cohort study.
His main research concerns Prostate cancer, Radiology, Prostate, Magnetic resonance imaging and Biopsy. Cancer and Internal medicine are the areas that his Prostate cancer study falls under. The concepts of his Radiology study are interwoven with issues in Targeted biopsy, PI-RADS, Confidence interval, Ablation Techniques and Ablation zone.
His Prostate research includes elements of Diffusion MRI, Retrospective cohort study, Nuclear medicine, Medical physics and Overdiagnosis. The study incorporates disciplines such as Multiparametric Magnetic Resonance Imaging, Receiver operating characteristic, Ultrasound and Image-Guided Biopsy in addition to Magnetic resonance imaging. His studies in Biopsy integrate themes in fields like Surgery, Disease, Cohort and Nomogram.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis
Veeru Kasivisvanathan;Antti S. Rannikko;Marcelo Borghi;Valeria Panebianco.
The New England Journal of Medicine (2018)
Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature
Jurgen J. Fütterer;Alberto Briganti;Pieter De Visschere;Mark Emberton.
European Urology (2015)
Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review.
Caroline M. Moore;Caroline M. Moore;Nicola L. Robertson;Nasr Arsanious;Thomas Middleton.
European Urology (2013)
Standards of Reporting for MRI-targeted Biopsy Studies (START) of the Prostate: Recommendations from an International Working Group.
Caroline M. Moore;Veeru Kasivisvanathan;Scott Eggener;Mark Emberton.
European Urology (2013)
Re: A Prospective, Blinded Comparison of Magnetic Resonance (MR) Imaging-Ultrasound Fusion and Visual Estimation in the Performance of MR-Targeted Prostate Biopsy: The PROFUS Trial
James S. Wysock;Andrew B. Rosenkrantz;William C. Huang;Michael D. Stifelman.
European Urology (2014)
Prostate Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Patients with a Prior Negative Biopsy: A Consensus Statement by AUA and SAR
Andrew B. Rosenkrantz;Sadhna Verma;Peter Choyke;Steven C. Eberhardt.
The Journal of Urology (2016)
Complications After Systematic, Random, and Image-guided Prostate Biopsy
Marco Borghesi;Hashim Ahmed;Robert Nam;Edward Schaeffer.
European Urology (2017)
Prostate cancer localization using multiparametric MR imaging: comparison of Prostate Imaging Reporting and Data System (PI-RADS) and Likert scales.
Andrew B. Rosenkrantz;Sooah Kim;Ruth P. Lim;Nicole Hindman.
Can Urinary PCA3 Supplement PSA in the Early Detection of Prostate Cancer
John T. Wei;Ziding Feng;Alan W. Partin;Elissa Brown.
Journal of Clinical Oncology (2014)
Prostate Cancer: Feasibility and Preliminary Experience of a Diffusional Kurtosis Model for Detection and Assessment of Aggressiveness of Peripheral Zone Cancer
Andrew B. Rosenkrantz;Eric E. Sigmund;Glyn Johnson;James S. Babb.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: